Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial

Jongwook Jeon,Su Young Lee,Seunghoon Lee,Changwoo Han,Geum Duck Park,Se-Joo Kim,Jhin Goo Chang,Woo Jung Kim
DOI: https://doi.org/10.1186/s12877-024-05366-7
IF: 4.07
2024-09-21
BMC Geriatrics
Abstract:Effective interventions for overall healthy subjects with mild cognitive impairment are currently limited. Choline alphoscerate (alpha glyceryl phosphorylcholine, αGPC) is a choline-containing phospholipid used to treat cognitive function impairments in specific neurological conditions. This study aimed to investigate the efficacy and safety of αGPC in individuals diagnosed with mild cognitive impairment.
geriatrics & gerontology,gerontology
What problem does this paper attempt to address?